Showing results (401-410 of 1,285) with videos related to
Sort By:
Pageof 129
Journal of Pediatric Gastroenterology and Nutrition|August 8, 2015
Physical Activity Is Prospectively Associated With Adolescent Nonalcoholic Fatty Liver DiseaseEmma L Anderson, Abigail Fraser, Laura D Howe, et al.Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2014
An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapyVijay U Rao, Andrey Pavlov, Micki Klearman, et al.Heart (British Cardiac Society)|May 15, 2021
Ramadan fasting: recommendations for patients with cardiovascular diseaseAbid Mohammed Akhtar, Nazim Ghouri, C Anwar A Chahal, et al.Clinical Nutrition (Edinburgh, Scotland)|August 1, 2026
Optimizing Weight Loss Maintenance: Can Continuous Glucose Monitoring Play a Role (OWL-CGM)? A Randomized Controlled Feasibility TrialNurul Zafirah Mohd Hatta, Cindy M Gray, Michelle Harvie, et al.Critical Care Medicine|March 1, 2006
Efficiency of oxygen administration: sequential gas delivery versus "flow into a cone" methodsMarat Slessarev, Ron Somogyi, David Preiss, et al.JAMA Ophthalmology|February 1, 2024
Diabetic Retinopathy and Quality of Life: A Systematic Review and Meta-AnalysisMohammed G Zayed, Waseem Karsan, Tunde Peto, et al.Medicine and Science in Sports and Exercise|April 25, 2025
Association of Daily Steps with Incident Non-Alcoholic Fatty Liver Disease: Evidence from the UK Biobank CohortEvelynne S Fulda, Laura Portas, Charlie Harper, et al.International Journal of Pediatric Obesity : IJPO : an Official Journal of the International Association for the Study of Obesity|December 17, 2008
Adiponectin in childhoodAlison N Jeffery, Michael J Murphy, Brad S Metcalf, et al.European Heart Journal|July 30, 2011
Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes TrialPeter S Sever, Neil R Poulter, Choon L Chang, et al.Diabetes Care|March 11, 2020
Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic BenefitsVasileios Liakopoulos, Stefan Franzén, Ann-Marie Svensson, et al.Pageof 129